Class Action Reform Passes Senate, Fast-Tracked In House
This article was originally published in The Tan Sheet
Executive Summary
The approval of a class action reform bill in the Senate is a key victory for pharmaceutical and supplement manufacturers who may face broad liability cases in the future
You may also be interested in...
Liability Reform Foes Point To COX-2s, Attack “FDA Defense”
COX-2 safety concerns have provided opponents of "FDA defense" provisions with a weapon against medical liability legislation as President Bush launches a campaign for his tort reform agenda
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands